UChicago Medicine

https://www.uchicagomedicine.org/

 

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts
A

35 y/o Male With Newly Diagnosed ALL: What Findings Are Traditionally Associated With Worse Outcomes? What Is the Most Appropriate Choice of Initial Therapy? How to Follow Response to Therapy?

By UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts FEATURING Adam Duvall, Peter Riedell, Ben Derman, Satyajit Kosuri
By UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts FEATURING Adam Duvall, Peter Riedell, Ben Derman, Satyajit Kosuri
38 views
March 8, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
6th Annual Updates from ASH 2020
05:11

ASH Updates on R/R MM: How to Choose Amongst Available Regimens at 1…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

B. Derman

265 views
21:25

ASH Updates on Frontline MM: What Is the Optimal Induction Regimen? …

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

B. Derman

324 views
11:49

35 y/o Male With Newly Diagnosed ALL: What Findings Are Traditionall…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

38 views
15:12

63 y/o Male With MCL: What Initial Therapy to Choose? What Would Be …

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

238 views
17:01

Newly Diagnosed MM Case Discussion: Classifying Patient Risk, and Ap…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

210 views
14:37

Expert Analysis of a Primary Myelofibrosis Case: What Tests Could Be…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Duvall, P. Riedell, B. Derman, S. Kosuri

107 views
24:46

ASH Updates on Non-Malignant Hematology: Mycophenolate for ITP, CTX0…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

M. Thirman

21 views
34:05

ASH Practice Changing Updates in AML: Maintenance Oral Aza, Lower In…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

C. DiNardo

131 views
30:26

ASH Advances in Cellular Therapy: Tisa-Cel in R/R B-ALL, Blinatumoma…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

A. Jakubowiak

36 views
27:46

ASH Highlights on High-Risk MDS in HMA Era: Oral HMAs, BCL2 Inhibiti…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

O. Odenike

27 views
16:45

Best of ASH on SCT in Leukemias: Who Should Be Referred Early for AS…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

S. Kosuri

82 views
16:23

ASH Update on SCT for Myeloid and Lymphoid Leukemias: Apamistamab as…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

S. Kosuri

61 views
17:31

ASH Updates on SoC in Lymphomas: How Beneficial Are Newly Approved B…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

161 views
07:31

ASH Updates on cHL: 2L Pembro + GVD, Brentuximab Vedotin & Checkpoin…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

121 views
06:44

ASH Updates on SoC in R/R MCL: How Active Are Novel BTKi & CAR-T The…

UChicago 6th Annual Updates from ASH 2020: Practice Changing Abstracts

P. Riedell

29 views